Efficacy and safety of sepiapterin versus sapropterin in patients with phenylketonuria: Results from the Phase 3, randomized, crossover, open-label, active-controlled AMPLIPHY trial
Maria Giżewska, Anita Inwood, Renata Tyčová, Suresh Vijay et autres
pl, au, cz, hk, gb, dk, nl, es, ca, it, si, fr, de, us (code pays fourni par la source)